Hot Topics: Surrogate Endpoints and Alzheimer's

(MedPage Today) -- Are biomarker-based endpoints adequate to prove efficacy in Alzheimer's drug trials? Two well-known specialists express doubt. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1fH4Gne